EUVIMEDEUVIMED entdecken
Crossref

Research on the mechanism of HOPX‐HDAC2 interaction inducing differentiation blockage in acute myeloid leukemia

Fang He iD, Yan Tu, Lihong Ni

Hematological Oncology · 2024

DOI: 10.1002/hon.3307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematological Oncology, 2024. Verfasst von Fang He und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Jinhua Municipal Central Hospital, Jinhua, China. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Histone Deacetylase 2, Cell Differentiation, Homeodomain Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Jinhua Science and Technology Plan Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Homeodomain‐only protein homeobox ( HOPX ) mainly exerts its transcriptional repression by physically sequestering the serum co‐repressor and recruiting histone deacetylase ( HDAC ), possessing important potential as a prognostic gene in acute myeloid leukemia (AML). HDACs play crucial roles in cell growth, gene regulation, and metabolism, and they are also important factors in promoting AML progression. Therefore, this project attempts to investigate whether HOPX affects AML progression by interacting with HDAC2 protein. Bioinformatics analysis was employed to identify potential prognostic genes in AML. Flow cytometry and MTT assays were performed to analyze the cellular biological functions of the AML prognostic marker HOPX . The interaction network of HOPX was analyzed using the Search Tool for the Retrieval of Interacting Genes database, and the interaction between HOPX and HDAC2 was observed using endogenous and exogenous immunoprecipitation. HOPX is highly expressed in AML cells. Further research uncovered that low expression of HOPX can repress the proliferation activity, anti‐apoptotic ability, and differentiation blockage of AML cells. Moreover, mechanistically, HOPX induced AML differentiation blockage and malignant progression through interaction with HDAC. HOPX can serve as a prognostic marker for AML and can interact with HDAC2 to induce AML differentiation blockage and malignant progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteHistone Deacetylase 2Cell DifferentiationHomeodomain ProteinsHumansCell ProliferationGene Expression Regulation, LeukemicApoptosisCell Line, TumorPrognosisTumor Suppressor Proteins

Stichwörter der Autor:innen

acute myeloid leukemiadifferentiation blockagehistone deacetylasehomeodomain‐only protein homeoboxprotein interaction

Substanzen

Histone Deacetylase 2HDAC2 protein, humanHomeodomain ProteinsHOPX protein, humanTumor Suppressor Proteins

Autor:innen und Institutionen

  • Department of Hematology, Jinhua Municipal Central Hospital, Jinhua, China.

ORCID-Profile: Fang He

Förderung

  • Jinhua Science and Technology Plan Project

Zitieren

APA

He, F., Tu, Y., & Ni, L. (2024). Research on the mechanism of HOPX‐HDAC2 interaction inducing differentiation blockage in acute myeloid leukemia. Hematological Oncology. https://doi.org/10.1002/hon.3307

Vancouver

He F, Tu Y, Ni L. Research on the mechanism of HOPX‐HDAC2 interaction inducing differentiation blockage in acute myeloid leukemia. Hematological Oncology. 2024. doi:10.1002/hon.3307

BibTeX
@article{He2024,
  author = {He, Fang and Tu, Yan and Ni, Lihong},
  title = {Research on the mechanism of HOPX‐HDAC2 interaction inducing differentiation blockage in acute myeloid leukemia},
  journal = {Hematological Oncology},
  year = {2024},
  doi = {10.1002/hon.3307}
}
Kostenlos starten →